Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth (2018)
- Authors:
- USP affiliated authors: SAITO, KELLY CRISTINA - ICB ; LEITE, KATIA RAMOS MOREIRA - FM ; KIMURA, EDNA TERUKO - ICB
- Unidades: ICB; FM
- DOI: 10.1186/s12885-018-4049-7
- Subjects: METILAÇÃO DE DNA; NEOPLASIAS; NEOPLASIAS PROSTÁTICAS; METÁSTASE NEOPLÁSICA
- Agências de fomento:
- Financiado pelo Programa de Desarrollo de las Ciencias Basicas (PEDECIBA), Uruguay
- Financiado pela Comision Sectorial de Investigacion Cientifica (CSIC), Uruguay
- Financiado pela Agencia Nacional de Investigacion e Innovacion (ANII), Uruguay
- Financiado pela Comision Honoraria de Lucha contra el Cancer (CHLC), Uruguay
- Language: Inglês
- Imprenta:
- Source:
- Título: BMC Cancer
- ISSN: 1471-2407
- Volume/Número/Paginação/Ano: v. 18, n. 1, article ID 127, 13 p., 2018
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc-nd
-
ABNT
FORT, Rafael Sebastián et al. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. BMC Cancer, v. 18, n. 1, p. 13 , 2018Tradução . . Disponível em: https://doi.org/10.1186/s12885-018-4049-7. Acesso em: 29 dez. 2025. -
APA
Fort, R. S., Mathó, C., Geraldo, M. V., Ottati, M. C., Yamashita, A. S., Saito, K. C., et al. (2018). Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. BMC Cancer, 18( 1), 13 . doi:10.1186/s12885-018-4049-7 -
NLM
Fort RS, Mathó C, Geraldo MV, Ottati MC, Yamashita AS, Saito KC, Leite KRM, Méndez M, Maedo N, Méndez L, Garat B, Kimura ET, Silveira JRS, Duhagon MA. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth [Internet]. BMC Cancer. 2018 ; 18( 1): 13 .[citado 2025 dez. 29 ] Available from: https://doi.org/10.1186/s12885-018-4049-7 -
Vancouver
Fort RS, Mathó C, Geraldo MV, Ottati MC, Yamashita AS, Saito KC, Leite KRM, Méndez M, Maedo N, Méndez L, Garat B, Kimura ET, Silveira JRS, Duhagon MA. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth [Internet]. BMC Cancer. 2018 ; 18( 1): 13 .[citado 2025 dez. 29 ] Available from: https://doi.org/10.1186/s12885-018-4049-7 - Nucleic acid recovery from thyroid fine-needle cytology slides
- Oncogenic changes in a new transgenic model of BRAFV600E in thyroid
- Thyroid and breast Cancer in 2 sisters with monoallelic mutations in the ataxia telangiectasia mutated (ATM) gene
- Thyroid follicular cell loss of differentiation induced by MicroRNA miR-17-92 cluster is attenuated by CRISPR/Cas9n gene silencing in anaplastic thyroid cancer
- Elemental characterization of oral cavity squamous cell carcinoma and its relationship with smoking, prognosis and survival
- Interplay of TGFβ signaling and microRNA in thyroid cell loss of differentiation and cancer progression
- Envolvimento de Rac1 na excitotoxicidade induzida por NMDA na retina de ratos
- The highly expressed FAM83F Protein in papillary thyroid cancer exerts a pro-oncogenic role in thyroid follicular cells
- Is prostate infarction and acute urinary retention a possible complication of severe COVID-19 infection?[Carta]
- Excitotoxicidade na retina de pintos: possível envolvimento dos receptores de glutamato e proteínas tamponantes de cálcio na sobrevivência neuronal
Informações sobre o DOI: 10.1186/s12885-018-4049-7 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
